Number of Shares
2.45 Mil
Current Holdings Value*
$8.55 Mil
% of Portfolio
2.76%
Total Estimate Gain
$-220,537.89
% of Total Estimate Gain
-2.70%

FOURSIXTHREE CAPITAL LP's Arbutus Biopharma Corp Holding Summary

As of 2025-03-31, FOURSIXTHREE CAPITAL LP held 2.45 Mil shares of Arbutus Biopharma Corp(ABUS), totaling $8.55 Mil. This investment constitutes 2.76% of their stock portfolio, and FOURSIXTHREE CAPITAL LP now holds 1.28% of the outstanding Arbutus Biopharma Corp(ABUS) stock.

The initial trade took place in 2025Q1. And since then FOURSIXTHREE CAPITAL LP has made 1 purchases of ABUS, at an average price of $3.33, for a total of 2.45 Mil shares. Based on historical transaction data and ABUS's current price of $3.24, FOURSIXTHREE CAPITAL LP's estimated gain on his ABUS holdings is $-220,537.89, reflecting a -2.70% gain to date.

FOURSIXTHREE CAPITAL LP ABUS ($3.24) Holding Chart

FOURSIXTHREE CAPITAL LP ABUS ($3.24) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1